Key result
Bariatric surgery should be considered for patients with heart failure and morbid obesity to reduce comorbidities, improve quality of life, and potentially enable heart transplantation eligibility.
Why the study?
Does bariatric surgery improve symptoms and quality of life in patients with heart failure and morbid obesity?
Does bariatric surgery improve symptoms and quality of life in patients with heart failure and morbid obesity?
Bariatric surgery should be considered for morbidly obese patients with heart failure to improve functional capacity, quality of life, and potentially enable eligibility for heart transplantation.
Supports potential benefit of bariatric surgery in obese HF; hypothesis-generating and requires RCTs before practice change.
Currently, the association between obesity and heart failure (HF) is increasingly known. Patients with advanced obesity who suffer from HF without an identifiable cause can be diagnosed as having obesity-associated cardiomyopathy. Although data suggest that obesity may reduce mortality in HF, weight loss, especially in the presence of morbid obesity, reduces symptoms and improves the quality of life of those patients. Bariatric surgery is the major treatment available for sustained weight loss in morbid obesity. Observational studies have demonstrated an improvement in ventricular structure and function of morbidly obese patients with HF who underwent that procedure. Thus, despite the risks, bariatric surgery should be considered for patients with HF, because of its potential for reducing associated comorbidities and improving quality of life and functional capacity, in addition to making eligible for heart transplantation those excluded due to high body mass index.
No takes yet. Share an insight, caveat, or question.
Mourilhe‐Rocha et al. (2019) conducted a review in Heart failure and morbid obesity. Bariatric surgery was evaluated. Bariatric surgery should be considered for patients with heart failure and morbid obesity to reduce comorbidities, improve quality of life, and potentially enable heart transplantation eligibility.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: